The successful treatment of severe aplastic anemia with autologous cord blood transplantation.
Cord blood transplantation has been used extensively in the allogeneic setting for acquired and genetic disorders of hematopoiesis. There is less experience in the utility of autologous cord blood transplantation, and there is great controversy about the role of autologous cord blood collection and storage. We report on the successful use of autologous cord blood transplantation for the treatment of severe aplastic anemia following fulminant hepatic failure and living related liver transplantation.
Fruchtman
Steven M
SM
Department of Medicine, Mount Sinai Medical Center, New York, New York 10029, USA. Steven.Fruchtman@msnyuhealth.org
Hurlet
Anne
A
Dracker
Robert
R
Isola
Luis
L
Goldman
Benjamin
B
Schneider
Benjamin L
BL
Emre
Sukru
S
D000328:Adult; D000741:Anemia, Aplastic / Q000209:etiology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D036101:Cord Blood Stem Cell Transplantation; D006801:Humans; D007223:Infant; D017114:Liver Failure, Acute / Q000150:complications / Q000628:therapy; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D014184:Transplantation, Homologous